The Connecticut Oncology Association represents more than 100 physicians and other health care professionals who care for cancer patients. The Society is a non-profit corporation devoted to the improvement of hematologic and oncologic care of patients.
Membership in the Society is open to physicians, allied health professionals, and institutions with a demonstrated interest and involvement in the care of patients with hematologic and oncologic disorders. It is also open to residents and fellows who are actively enrolled in a full-time residency program in hematology or oncology in Connecticut or who are in an appropriate fellowship program. Corporate entities involved in the care and treatment of cancer patients may also become members.
The Connecticut Oncology Association is grateful to our Corporate Sponsors, whose donations help us fulfill our mission.
Corporate Sponsor Virtual Broadcast:
Current Policy/Advocacy Concerns for CT patients
Anthem Oncology Dose Reduction Program for Medicare Advantage Patients
09/30/2019 AstraZeneca - Tagrisso is the only 1st-line treatment for EGFR-mutated non-small cell lung cancer to deliver a median overall survival of more than three years Press Release
08/16/2-19 Celgene -
U.S. FDA Approves INREBIC® (Fedratinib) as First New Treatment in Nearly a Decade for Patients With Myelofibrosis Press Release